Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001645113-24-000036
Filing Date
2024-12-17
Accepted
2024-12-16 19:54:38
Documents
15
Period of Report
2024-08-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A nvcr-20240830.htm   iXBRL 8-K/A 33321
2 EX-10.1 ceoemploymentagreementex101.htm EX-10.1 111547
3 EX-10.2 senioradvisortoceoemployme.htm EX-10.2 143099
  Complete submission text file 0001645113-24-000036.txt   470341

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nvcr-20240830.xsd EX-101.SCH 1882
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nvcr-20240830_lab.xml EX-101.LAB 21801
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nvcr-20240830_pre.xml EX-101.PRE 12579
17 EXTRACTED XBRL INSTANCE DOCUMENT nvcr-20240830_htm.xml XML 2709
Mailing Address NO. 4 THE FORUM GRENVILLE STREET ST. HELIER Y9 JE2 4UF
Business Address NO. 4 THE FORUM GRENVILLE STREET ST. HELIER Y9 JE2 4UF 44 (0)15 3475 6700
NovoCure Ltd (Filer) CIK: 0001645113 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37565 | Film No.: 241553314
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)